Cambridge GPs launch ‘pill on a string’ cancer check

Cambridge device to spot early signs of cancer is being trialled for the first time to GP patients in the UK.

Cambridge begins world-first COVID-19 vaccine booster study

Researchers in Cambridge have welcomed their first participants in a new UK study to understand the effects of a ‘booster’ dose of a COVID-19 vaccine.

World-first covid-19 vaccine booster study launches in Eastern region

Volunteers from the East of England will soon be able to receive a third ‘booster’ COVID-19 vaccine through a new Government-funded clinical trial.

International Clinical Trials Day 2021

To celebrate International Clinical Trials Day 2021, we are publishing a series of posts on social media of personal stories of what research means to them.

Royal Society elects Professor Sadaf Farooqi

The Royal Society announced in May that Professor Sadaf Farooqi, Professor of Metabolism and Medicine, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, is among this year’s newly elected fellows.
a man with his thumb up

Why I took part in Covid-19 Research

With the help of research, we now have insights on how to treat Covid-19, but still very little information with the long-term effects of COVID-19, particularly what the ongoing medical, psychological and rehabilitation needs are for this group of patients, and enable them to make as full a recovery as possible.

Covid-19 Research1 Year on: Meet Our Outreach Team

The NIHR Cambridge CRF are supporting COVID Platform Trials, 7 days a week, working alongside the medics in screening patients who meet the criteria for Covid-19 Therapeutic Trials: TACTIC R, TACTIC E, DARE-19 and RECOVERY. 

Honour for expert who set up early testing for Covid-19

Dr Michael Weekes, has been awarded a British Empire Medal for his services to for services to the NHS during Covid-19.

Covid-19: Oxford-AstraZeneca vaccine approved for use in UK

On 30 December 2020, we woke up to the news that we had been waiting for, Oxford AstraZeneca vaccine has been approved!